TRIM16 and cancer: The TRIM16‐depletion cripples these machinery leading to the accumulation of toxic misfolded proteins or aggregates intermediates and makes the cancer cell vulnerable to oxidative or proteotoxic stresses in vitro and in vivo (Fig 7).